Semaglutide (administered by PDS290 pen-injector) clinical trials

Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monogenic Obesity in Clinical Practice

This study looks at how a weekly injection called semaglutide helps teenagers aged 12 to 21 with a specific type of genetic obesity. Researchers will see how it affects their weight, hunger, mood, and overall well-being over 68 weeks.